Identification and biology of α-secretase

Journal of Neurochemistry

Volumn 120, Issue SUPPL. 1, 2012, Pages 34-45

  Vingtdeux, Valérie ^a   Marambaud, Philippe ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

secretase; ADAM proteases; Alzheimer's disease; APP

Indexed keywords

ADAM PROTEIN; ADAM10 ENDOPEPTIDASE; ADAM17 PROTEIN; ADAM9 PROTEIN; ALPHA SECRETASE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; DIMERIZATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REGULATION; ENZYME RELEASE; EXCITOTOXICITY; GENE DELETION; GENE EXPRESSION; HUMAN; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; HUMANS; PLAQUE, AMYLOID; PROTEIN ISOFORMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84655164281     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2011.07477.x     Document Type: Review

References (142)

1. Adlerz L., Holback S., Multhaup G., and, Iverfeldt K., (2007) IGF-1-induced processing of the amyloid precursor protein family is mediated by different signaling pathways. J. Biol. Chem. 282, 10203-10209. (Pubitemid 47093446)
2. Ahmad M., Takino T., Miyamori H., Yoshizaki T., Furukawa M., and, Sato H., (2006) Cleavage of amyloid-beta precursor protein (APP) by membrane-type matrix metalloproteinases. J. Biochem. 139, 517-526. (Pubitemid 43667115)
3. Alfa Cisse M., Sunyach C., Slack B. E., Fisher A., Vincent B., and, Checler F., (2007) M1 and M3 muscarinic receptors control physiological processing of cellular prion by modulating ADAM17 phosphorylation and activity. J. Neurosci. 27, 4083-4092. (Pubitemid 46597172)
4. Allinson T. M., Parkin E. T., Condon T. P., Schwager S. L., Sturrock E. D., Turner A. J., and, Hooper N. M., (2004) The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein. Eur. J. Biochem. 271, 2539-2547. (Pubitemid 38813584)
5. Allsop D., Yamamoto T., Kametani F., Miyazaki N., and, Ishii T., (1991) Alzheimer amyloid beta/A4 peptide binding sites and a possible 'APP-secretase' activity associated with rat brain cortical membranes. Brain Res. 551, 1-9.
6. Almkvist O., Basun H., Wagner S. L., Rowe B. A., Wahlund L. O., and, Lannfelt L., (1997) Cerebrospinal fluid levels of alpha-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch. Neurol. 54, 641-644. (Pubitemid 27204251)
7. Amour A., Slocombe P. M., Webster A., et al. (1998) TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett. 435, 39-44. (Pubitemid 28432011)
8. Amour A., Knight C. G., Webster A., Slocombe P. M., Stephens P. E., Knauper V., Docherty A. J., and, Murphy G., (2000) The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3. FEBS Lett. 473, 275-279. (Pubitemid 30249139)
9. Anders A., Gilbert S., Garten W., Postina R., and, Fahrenholz F., (2001) Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 15, 1837-1839.
10. Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I., and, Robakis N. K., (1991) Exact cleavage site of Alzheimer amyloid precursor in neuronal PC-12 cells. Neurosci. Lett. 128, 126-128.
11. Arikkath J., and, Reichardt L. F., (2008) Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci. 31, 487-494.
12. Arribas J., and, Massague J., (1995) Transforming growth factor-alpha and beta-amyloid precursor protein share a secretory mechanism. J. Cell Biol. 128, 433-441.
13. Arribas J., Coodly L., Vollmer P., Kishimoto T. K., Rose-John S., and, Massague J., (1996) Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors. J. Biol. Chem. 271, 11376-11382. (Pubitemid 26155976)
14. Asai M., Hattori C., Szabo B., Sasagawa N., Maruyama K., Tanuma S., and, Ishiura S., (2003) Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase. Biochem. Biophys. Res. Commun. 301, 231-235. (Pubitemid 36268873)
15. Baker A. H., Edwards D. R., and, Murphy G., (2002) Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J. Cell Sci. 115, 3719-3727. (Pubitemid 35203598)
16. Baki L., Marambaud P., Efthimiopoulos S., et al. (2001) Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proc. Natl. Acad. Sci. USA 98, 2381-2386. (Pubitemid 32209491)
17. Bernstein H. G., Bukowska A., Krell D., Bogerts B., Ansorge S., and, Lendeckel U., (2003) Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J. Neurocytol. 32, 153-160. (Pubitemid 38019307)
18. Black R. A., Rauch C. T., Kozlosky C. J., et al. (1997) A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385, 729-733. (Pubitemid 27098094)
19. Blacker M., Noe M. C., Carty T. J., Goodyer C. G., and, LeBlanc A. C., (2002) Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. J. Neurochem. 83, 1349-1357. (Pubitemid 35477474)
20. Blobel C. P., (2005) ADAMs: key components in EGFR signalling and development. Nat. Rev. Mol. Cell Biol. 6, 32-43. (Pubitemid 40064897)
21. Buxbaum J. D., Koo E. H., and, Greengard P., (1993) Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide. Proc. Natl. Acad. Sci. USA 90, 9195-9198. (Pubitemid 23306479)
22. Buxbaum J. D., Liu K. N., Luo Y., Slack J. L., Stocking K. L., Peschon J. J., Johnson R. S., Castner B. J., Cerretti D. P., and, Black R. A., (1998) Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J. Biol. Chem. 273, 27765-27767. (Pubitemid 28496060)
23. Caccamo A., Oddo S., Billings L. M., Green K. N., Martinez-Coria H., Fisher A., and, LaFerla F. M., (2006) M1 receptors play a central role in modulating AD-like pathology in transgenic mice. Neuron 49, 671-682. (Pubitemid 43290127)
24. Caille I., Allinquant B., Dupont E., Bouillot C., Langer A., Muller U., and, Prochiantz A., (2004) Soluble form of amyloid precursor protein regulates proliferation of progenitors in the adult subventricular zone. Development 131, 2173-2181. (Pubitemid 38702048)
25. Caporaso G. L., Gandy S. E., Buxbaum J. D., Ramabhadran T. V., and, Greengard P., (1992) Protein phosphorylation regulates secretion of Alzheimer beta/A4 amyloid precursor protein. Proc. Natl. Acad. Sci. USA 89, 3055-3059.
26. Carey R. M., Blusztajn J. K., and, Slack B. E., (2011) Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin. BMC Cell Biol. 12, 20.
27. Checler F., (1995) Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65, 1431-1444.
28. Cisse M. A., Sunyach C., Lefranc-Jullien S., Postina R., Vincent B., and, Checler F., (2005) The disintegrin ADAM9 indirectly contributes to the physiological processing of cellular prion by modulating ADAM10 activity. J. Biol. Chem. 280, 40624-40631. (Pubitemid 41780553)
29. Cisse M., Braun U., Leitges M., Fisher A., Pages G., Checler F., and, Vincent B., (2011a) ERK1-independent alpha-secretase cut of beta-amyloid precursor protein via M1 muscarinic receptors and PKCalpha/epsilon. Mol. Cell. Neurosci. 47, 223-232.
30. Cisse M., Duplan E., Guillot-Sestier M. V., Rumigny J., Bauer C., Pages G., Orzechowski H. D., Slack B. E., Checler F., and, Vincent B., (2011b) The extracellular regulated kinase-1 (ERK1) controls regulated {alpha}-secretase- mediated processing, promoter transactivation and mRNA levels of the cellular prion protein. J. Biol. Chem. 286, 29192-29206.
31. Clement A. B., Hanstein R., Schroder A., Nagel H., Endres K., Fahrenholz F., and, Behl C., (2008) Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience 152, 459-468.
32. Copanaki E., Chang S., Vlachos A., Tschape J. A., Muller U. C., Kogel D., and, Deller T., (2010) sAPPalpha antagonizes dendritic degeneration and neuron death triggered by proteasomal stress. Mol. Cell. Neurosci. 44, 386-393.
33. Davis-Salinas J., Saporito-Irwin S. M., Donovan F. M., Cunningham D. D., and, Van Nostrand W. E., (1994) Thrombin receptor activation induces secretion and nonamyloidogenic processing of amyloid beta-protein precursor. J. Biol. Chem. 269, 22623-22627. (Pubitemid 24273369)
34. De Strooper B., and, Annaert W., (2010) Novel research horizons for presenilins and gamma-secretases in cell biology and disease. Annu. Rev. Cell Dev. Biol. 26, 235-260.
35. Delarasse C., Auger R., Gonnord P., Fontaine B., and, Kanellopoulos J. M., (2011) The purinergic receptor P2X7 triggers alpha-secretase-dependent processing of the amyloid precursor protein. J. Biol. Chem. 286, 2596-2606.
36. Diaz-Rodriguez E., Montero J. C., Esparis-Ogando A., Yuste L., and, Pandiella A., (2002) Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol. Biol. Cell 13, 2031-2044. (Pubitemid 34651490)
37. Dickson D. W., (2009) Neuropathology of non-Alzheimer degenerative disorders. Int. J. Clin. Exp. Pathol. 3 (1), 1-23.
38. Doedens J. R., and, Black R. A., (2000) Stimulation-induced down-regulation of tumor necrosis factor-alpha converting enzyme. J. Biol. Chem. 275, 14598-14607. (Pubitemid 30339750)
39. Duyckaerts C., Delatour B., and, Potier M. C., (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 5-36.
40. Edwards D. R., Handsley M. M., and, Pennington C. J., (2008) The ADAM metalloproteinases. Mol. Aspects Med. 29, 258-289.
41. Epis R., Marcello E., Gardoni F., et al. (2010) Blocking ADAM10 synaptic trafficking generates a model of sporadic Alzheimer's disease. Brain 133, 3323-3335.
42. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and, Ward P. J., (1990) Cleavage of amyloid beta peptide during constitutive processing of its precursor. Science 248, 1122-1124.
43. Faure J., Lachenal G., Court M., et al. (2006) Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 31, 642-648.
44. Fellgiebel A., Kojro E., Muller M. J., Scheurich A., Schmidt L. G., and, Fahrenholz F., (2009) CSF APPs alpha and phosphorylated tau protein levels in mild cognitive impairment and dementia of Alzheimer's type. J. Geriatr. Psychiatry Neurol. 22, 3-9.
45. Fevrier B., and, Raposo G., (2004) Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr. Opin. Cell Biol. 16, 415-421. (Pubitemid 38903148)
46. Furukawa K., and, Mattson M. P., (1998) Secreted amyloid precursor protein alpha selectively suppresses N-methyl-D-aspartate currents in hippocampal neurons: involvement of cyclic GMP. Neuroscience 83, 429-438. (Pubitemid 28062633)
47. Furukawa K., Barger S. W., Blalock E. M., and, Mattson M. P., (1996a) Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein. Nature 379, 74-78. (Pubitemid 26008138)
48. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M., and, Mattson M. P., (1996b) Increased activity-regulating and neuroprotective efficacy of alpha-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1896. (Pubitemid 26349661)
49. Georgakopoulos A., Marambaud P., Efthimiopoulos S., et al. (1999) Presenilin-1 forms complexes with the cadherin/catenin cell-cell adhesion system and is recruited to intercellular and synaptic contacts. Mol. Cell 4, 893-902. (Pubitemid 30054896)
50. Georgakopoulos A., Litterst C., Ghersi E., Baki L., Xu C., Serban G., and, Robakis N. K., (2006) Metalloproteinase/presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J. 25, 1242-1252.
51. Giulian D., Haverkamp L. J., Yu J., Karshin W., Tom D., Li J., Kazanskaia A., Kirkpatrick J., and, Roher A. E., (1998) The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease. J. Biol. Chem. 273, 29719-29726. (Pubitemid 28509983)
52. Golde T. E., Petrucelli L., and, Lewis J., (2010) Targeting Abeta and tau in Alzheimer's disease, an early interim report. Exp. Neurol. 223, 252-266.
53. Gralle M., Botelho M. G., and, Wouters F. S., (2009) Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers. J. Biol. Chem. 284, 15016-15025.
54. Hartmann D., de Strooper B., Serneels L., et al. (2002) The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts. Hum. Mol. Genet. 112, 2615-2624. (Pubitemid 35174691)
55. Higashi S., and, Miyazaki K., (2003) Novel processing of beta-amyloid precursor protein catalyzed by membrane type 1 matrix metalloproteinase releases a fragment lacking the inhibitor domain against gelatinase A. Biochemistry 422, 6514-6526. (Pubitemid 36665827)
56. Hoe H. S., Cooper M. J., Burns M. P., Lewis P. A., van der Brug M., Chakraborty G., Cartagena C. M., Pak D. T., Cookson M. R., and, Rebeck G. W., (2007) The metalloprotease inhibitor TIMP-3 regulates amyloid precursor protein and apolipoprotein E receptor proteolysis. J. Neurosci. 274, 10895-10905. (Pubitemid 47535874)
57. Hooper N. M., Keen J., Pappin D. J., and, Turner A. J., (1987) Pig kidney angiotensin converting enzyme. Purification and characterization of amphipathic and hydrophilic forms of the enzyme establishes C-terminal anchorage to the plasma membrane. Biochem. J. 247, 85-93.
58. Horiuchi K., Le Gall S., Schulte M., Yamaguchi T., Reiss K., Murphy G., Toyama Y., Hartmann D., Saftig P., and, Blobel C. P., (2007) Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx. Mol. Biol. Cell 18, 176-188. (Pubitemid 46066719)
59. Hung A. Y., Haass C., Nitsch R. M., Qiu W. Q., Citron M., Wurtman R. J., Growdon J. H., and, Selkoe D. J., (1993) Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268, 22959-22962. (Pubitemid 23327996)
60. Hwang E. M., Kim S. K., Sohn J. H., Lee J. Y., Kim Y., Kim Y. S., and, Mook-Jung I., (2006) Furin is an endogenous regulator of alpha-secretase associated APP processing. Biochem. Biophys. Res. Commun. 349, 654-659. (Pubitemid 44344566)
61. Jacobsen K. T., Adlerz L., Multhaup G., and, Iverfeldt K., (2010) Insulin-like growth factor-1 (IGF-1)-induced processing of amyloid-beta precursor protein (APP) and APP-like protein 2 is mediated by different metalloproteinases. J. Biol. Chem. 285, 10223-10231.
62. Janes P. W., Saha N., Barton W. A., Kolev M. V., Wimmer-Kleikamp S. H., Nievergall E., Blobel C. P., Himanen J. P., Lackmann M., and, Nikolov D. B., (2005) Adam meets Eph: an ADAM substrate recognition module acts as a molecular switch for ephrin cleavage in trans. Cell 123, 291-304. (Pubitemid 41457218)
63. Jin L. W., Ninomiya H., Roch J. M., Schubert D., Masliah E., Otero D. A., and, Saitoh T., (1994) Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J. Neurosci. 14, 5461-5470. (Pubitemid 24279065)
64. Jorissen E., Prox J., Bernreuther C., et al. (2010) The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J. Neurosci. 301, 4833-4844.
65. Kamenetz F., Tomita T., Hsieh H., Seabrook G., Borchelt D., Iwatsubo T., Sisodia S., and, Malinow R., (2003) APP processing and synaptic function. Neuron 37, 925-937. (Pubitemid 36398299)
66. Karkkainen I., Rybnikova E., Pelto-Huikko M., and, Huovila A. P., (2000) Metalloprotease-disintegrin (ADAM) genes are widely and differentially expressed in the adult CNS. Mol. Cell. Neurosci. 15, 547-560. (Pubitemid 30436928)
67. Killock D. J., and, Ivetic A., (2010) The cytoplasmic domains of TNFalpha-converting enzyme (TACE/ADAM17) and L-selectin are regulated differently by p38 MAPK and PKC to promote ectodomain shedding. Biochem. J. 428, 293-304.
68. Kim M. L., Zhang B., Mills I. P., Milla M. E., Brunden K. R., and, Lee V. M., (2008) Effects of TNFalpha-converting enzyme inhibition on amyloid beta production and APP processing in vitro and in vivo. J. Neurosci. 284, 12052-12061.
69. Koike H., Tomioka S., Sorimachi H., Saido T. C., Maruyama K., Okuyama A., Fujisawa-Sehara A., Ohno S., Suzuki K., and, Ishiura S., (1999) Membrane-anchored metalloprotease MDC9 has an alpha-secretase activity responsible for processing the amyloid precursor protein. Biochem. J. 343, 371-375. (Pubitemid 29511770)
70. Kojro E., Gimpl G., Lammich S., Marz W., and, Fahrenholz F., (2001) Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc. Natl. Acad. Sci. USA 981, 5815-5820. (Pubitemid 32435725)
71. Kojro E., Postina R., Buro C., Meiringer C., Gehrig-Burger K., and, Fahrenholz F., (2006) The neuropeptide PACAP promotes the alpha-secretase pathway for processing the Alzheimer amyloid precursor protein. FASEB J. 20, 512-514. (Pubitemid 46671233)
72. Komano H., Seeger M., Gandy S., Wang G. T., Krafft G. A., and, Fuller R. S., (1998) Involvement of cell surface glycosyl-phosphatidylinositol-linked aspartyl proteases in alpha-secretase-type cleavage and ectodomain solubilization of human Alzheimer beta-amyloid precursor protein in yeast. J. Biol. Chem. 273, 31648-31651. (Pubitemid 29177092)
73. Kopan R., and, Ilagan M. X., (2009) The canonical Notch signaling pathway: unfolding the activation mechanism. Cell 137, 216-233.
74. Kuester M., Kemmerzehl S., Dahms S. O., Roeser D., and, Than M. E., (2011) The crystal structure of death receptor 6 (DR6): a potential receptor of the amyloid precursor protein (APP). J. Mol. Biol. 409, 189-201.
75. Kuhn P. H., Wang H., Dislich B., Colombo A., Zeitschel U., Ellwart J. W., Kremmer E., Rossner S., and, Lichtenthaler S. F., (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J. 291, 3020-3032.
76. La Marca R., Cerri F., Horiuchi K., Bachi A., Feltri M. L., Wrabetz L., Blobel C. P., Quattrini A., Salzer J. L., and, Taveggia C., (2011) TACE (ADAM17) inhibits Schwann cell myelination. Nat. Neurosci. 14, 857-865.
77. Lachenal G., Pernet-Gallay K., Chivet M., Hemming F. J., Belly A., Bodon G., Blot B., Haase G., Goldberg Y., and, Sadoul R., (2011) Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci. 46, 409-418.
78. Lambert J. C., and, Amouyel P., (2007) Genetic heterogeneity of Alzheimer's disease: complexity and advances. Psychoneuroendocrinology 32, S62-S70. (Pubitemid 47211638)
79. Lammich S., Kojro E., Postina R., Gilbert S., Pfeiffer R., Jasionowski M., Haass C., and, Fahrenholz F., (1999) Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc. Natl. Acad. Sci. USA 96, 3922-3927. (Pubitemid 29169012)
80. Lannfelt L., Basun H., Wahlund L. O., Rowe B. A., and, Wagner S. L., (1995) Decreased alpha-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's disease. Nat. Med. 1, 829-832.
81. Lee R. K., Wurtman R. J., Cox A. J., and, Nitsch R. M., (1995) Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. Natl. Acad. Sci. USA 921, 8083-8087.
82. Lichtenthaler S. F., (2011) Alpha-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J. Neurochem. 116, 10-21.
83. Lopez-Perez E., Seidah N. G., and, Checler F., (1999) Proprotein convertase activity contributes to the processing of the Alzheimer's beta-amyloid precursor protein in human cells: evidence for a role of the prohormone convertase PC7 in the constitutive alpha-secretase pathway. J. Neurochem. 73, 2056-2062. (Pubitemid 29491820)
84. Lopez-Perez E., Zhang Y., Frank S. J., Creemers J., Seidah N., and, Checler F., (2001) Constitutive alpha-secretase cleavage of the beta-amyloid precursor protein in the furin-deficient LoVo cell line: involvement of the pro-hormone convertase 7 and the disintegrin metalloprotease ADAM10. J. Neurochem. 76, 1532-1539. (Pubitemid 32198257)
85. Malinverno M., Carta M., Epis R., Marcello E., Verpelli C., Cattabeni F., Sala C., Mulle C., Di Luca M., and, Gardoni F., (2010) Synaptic localization and activity of ADAM10 regulate excitatory synapses through N-cadherin cleavage. J. Neurosci. 304, 16343-16355.
86. Marambaud P., and, Robakis N. K., (2005) Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation. Genes Brain Behav. 4, 134-146. (Pubitemid 40559140)
87. Marambaud P., Chevallier N., Barelli H., Wilk S., and, Checler F., (1997) Proteasome contributes to the alpha-secretase pathway of amyloid precursor protein in human cells. J. Neurochem. 68, 698-703. (Pubitemid 27044732)
88. Marambaud P., Shioi J., Serban G., et al. (2002) A presenilin-1/gamma- secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. EMBO J. 21, 1948-1956. (Pubitemid 34437192)
89. Marambaud P., Wen P. H., Dutt A., Shioi J., Takashima A., Siman R., and, Robakis N. K., (2003) A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114, 635-645. (Pubitemid 37159259)
90. Marcello E., Gardoni F., Mauceri D., et al. (2007) Synapse-associated protein-97 mediates alpha-secretase ADAM10 trafficking and promotes its activity. J. Neurosci. 27, 1682-1691. (Pubitemid 46280085)
91. Marcinkiewicz M., and, Seidah N. G., (2000) Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J. Neurochem. 75, 2133-2143.
92. Maretzky T., Reiss K., Ludwig A., Buchholz J., Scholz F., Proksch E., de Strooper B., Hartmann D., and, Saftig P., (2005a) ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. Proc. Natl. Acad. Sci. USA 102, 9182-9187. (Pubitemid 40923538)
93. Maretzky T., Schulte M., Ludwig A., Rose-John S., Blobel C., Hartmann D., Altevogt P., Saftig P., and, Reiss K., (2005b) L1 is sequentially processed by two differently activated metalloproteases and presenilin/gamma-secretase and regulates neural cell adhesion, cell migration, and neurite outgrowth. Mol. Cell. Biol. 252, 9040-9053. (Pubitemid 41429092)
94. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., and, Rydel R. E., (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254. (Pubitemid 23079546)
95. McDermott J. R., and, Gibson A. M., (1991) The processing of Alzheimer A4/beta-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide. Biochem. Biophys. Res. Commun. 179, 1148-1154.
96. Merlos-Suarez A., Fernandez-Larrea J., Reddy P., Baselga J., and, Arribas J., (1998) Pro-tumor necrosis factor-alpha processing activity is tightly controlled by a component that does not affect notch processing. J. Biol. Chem. 273, 24955-24962. (Pubitemid 28455004)
97. Meziane H., Dodart J. C., Mathis C., Little S., Clemens J., Paul S. M., and, Ungerer A., (1998) Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. USA 952, 12683-12688. (Pubitemid 28483825)
98. Moechars D., Lorent K., De Strooper B., Dewachter I., and, Van Leuven F., (1996) Expression in brain of amyloid precursor protein mutated in the alpha-secretase site causes disturbed behavior, neuronal degeneration and premature death in transgenic mice. EMBO J. 15, 1265-1274. (Pubitemid 26093462)
99. Moss M. L., Jin S. L., Milla M. E., et al. (1997) Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385, 733-736. (Pubitemid 27098095)
100. Muraguchi T., Takegami Y., Ohtsuka T., et al. (2007) RECK modulates Notch signaling during cortical neurogenesis by regulating ADAM10 activity. Nat. Neurosci. 10, 838-845. (Pubitemid 47013438)
101. Naus S., Reipschlager S., Wildeboer D., Lichtenthaler S. F., Mitterreiter S., Guan Z., Moss M. L., and, Bartsch J. W., (2006) Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8. Biol. Chem. 387, 337-346.
102. Nelson W. J., (2008) Regulation of cell-cell adhesion by the cadherin-catenin complex. Biochem. Soc. Trans. 36, 149-155. (Pubitemid 351570584)
103. Nikolaev A., McLaughlin T., O'Leary D. D., and, Tessier-Lavigne M., (2009) APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457, 981-989.
104. Nitsch R. M., Slack B. E., Wurtman R. J., and, Growdon J. H., (1992) Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
105. Nitsch R. M., Kim C., and, Growdon J. H., (1998) Vasopressin and bradykinin regulate secretory processing of the amyloid protein precursor of Alzheimer's disease. Neurochem. Res. 23, 807-814. (Pubitemid 28173588)
106. Pan D., and, Rubin G. M., (1997) Kuzbanian controls proteolytic processing of Notch and mediates lateral inhibition during Drosophila and vertebrate neurogenesis. Cell 90, 271-280. (Pubitemid 27329712)
107. Parkin E., and, Harris B., (2009) A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J. Neurochem. 108, 1464-1479.
108. Pastor P., and, Goate A. M., (2004) Molecular genetics of Alzheimer's disease. Curr. Psychiatry Rep. 6, 125-133. (Pubitemid 38899262)
109. Postina R., Schroeder A., Dewachter I., et al. (2004) A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model. J. Clin. Invest. 113, 1456-1464. (Pubitemid 39071701)
110. Quast T., Wehner S., Kirfel G., Jaeger K., De Luca M., and, Herzog V., (2003) sAPP as a regulator of dendrite motility and melanin release in epidermal melanocytes and melanoma cells. FASEB J. 171, 1739-1741.
111. Refolo L. M., Salton S. R., Anderson J. P., Mehta P., and, Robakis N. K., (1989) Nerve and epidermal growth factors induce the release of the Alzheimer amyloid precursor from PC 12 cell cultures. Biochem. Biophys. Res. Commun. 164, 664-670. (Pubitemid 19280320)
112. Reiss K., Maretzky T., Ludwig A., Tousseyn T., de Strooper B., Hartmann D., and, Saftig P., (2005) ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. EMBO J. 24, 742-752. (Pubitemid 40396104)
113. Ring S., Weyer S. W., Kilian S. B., et al. (2007) The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J. Neurosci. 272, 7817-7826. (Pubitemid 47093823)
114. Roberts S. B., Ripellino J. A., Ingalls K. M., Robakis N. K., and, Felsenstein K. M., (1994) Non-amyloidogenic cleavage of the beta-amyloid precursor protein by an integral membrane metalloendopeptidase. J. Biol. Chem. 269, 3111-3116.
115. Roghani M., Becherer J. D., Moss M. L., Atherton R. E., Erdjument-Bromage H., Arribas J., Blackburn R. K., Weskamp G., Tempst P., and, Blobel C. P., (1999) Metalloprotease-disintegrin MDC9: intracellular maturation and catalytic activity. J. Biol. Chem. 274, 3531-3540. (Pubitemid 29077194)
116. Rooke J., Pan D., Xu T., and, Rubin G. M., (1996) KUZ, a conserved metalloprotease-disintegrin protein with two roles in Drosophila neurogenesis. Science 273, 1227-1231. (Pubitemid 26293213)
117. Sahin U., Weskamp G., Kelly K., Zhou H. M., Higashiyama S., Peschon J., Hartmann D., Saftig P., and, Blobel C. P., (2004) Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell Biol. 164, 769-779. (Pubitemid 38282960)
118. Saitoh T., Sundsmo M., Roch J. M., Kimura N., Cole G., Schubert D., Oltersdorf T., and, Schenk D. B., (1989) Secreted form of amyloid beta protein precursor is involved in the growth regulation of fibroblasts. Cell 58, 615-622. (Pubitemid 19210955)
119. Sambamurti K., Sevlever D., Koothan T., et al. (1999) Glycosylphosphatidylinositol-anchored proteins play an important role in the biogenesis of the Alzheimer's amyloid beta-protein. J. Biol. Chem. 274, 26810-26814.
120. Selkoe D. J., (2001) Alzheimer's disease: genes, proteins, and therapy. Physiol. Rev. 81, 741-766. (Pubitemid 32267077)
121. Sennvik K., Fastbom J., Blomberg M., Wahlund L. O., Winblad B., and, Benedikz E., (2000) Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients. Neurosci. Lett. 278, 169-172. (Pubitemid 30009484)
122. Sisodia S. S., (1992) Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc. Natl. Acad. Sci. USA 891, 6075-6079.
123. Six E., Ndiaye D., Laabi Y., Brou C., Gupta-Rossi N., Israel A., and, Logeat F., (2003) The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc. Natl. Acad. Sci. USA 100, 7638-7643. (Pubitemid 36760022)
124. Skovronsky D. M., Fath S., Lee V. M., and, Milla M. E., (2001) Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques. J. Neurobiol. 49, 40-46.
125. Slack B. E., Ma L. K., and, Seah C. C., (2001) Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-alpha converting enzyme. Biochem. J. 357, 787-794. (Pubitemid 32735158)
126. Soond S. M., Everson B., Riches D. W., and, Murphy G., (2005) ERK-mediated phosphorylation of Thr735 in TNFalpha-converting enzyme and its potential role in TACE protein trafficking. J. Cell Sci. 118, 2371-2380. (Pubitemid 40873077)
127. Srinivasan B., Wang Z., Brun-Zinkernagel A. M., Collier R. J., Black R. A., Frank S. J., Barker P. A., and, Roque R. S., (2007) Photic injury promotes cleavage of p75NTR by TACE and nuclear trafficking of the p75 intracellular domain. Mol. Cell. Neurosci. 36, 449-461. (Pubitemid 47633972)
128. Srour N., Lebel A., McMahon S., Fournier I., Fugere M., Day R., and, Dubois C. M., (2003) TACE/ADAM-17 maturation and activation of sheddase activity require proprotein convertase activity. FEBS Lett. 554, 275-283. (Pubitemid 37412499)
129. Stoeck A., Keller S., Riedle S., Sanderson M. P., Runz S., Le Naour F., Gutwein P., Ludwig A., Rubinstein E., and, Altevogt P., (2006) A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44. Biochem. J. 393 (Pt 3), 609-618. (Pubitemid 43163801)
130. Tachida Y., Nakagawa K., Saito T., et al. (2008) Interleukin-1 beta up-regulates TACE to enhance alpha-cleavage of APP in neurons: resulting decrease in Abeta production. J. Neurochem. 104, 1387-1393. (Pubitemid 351293352)
131. Talamagas A. A., Efthimiopoulos S., Tsilibary E. C., Figueiredo-Pereira M. E., and, Tzinia A. K., (2007) Abeta(1-40)-induced secretion of matrix metalloproteinase-9 results in sAPPalpha release by association with cell surface APP. Neurobiol. Dis. 28, 304-315. (Pubitemid 350123595)
132. Tanabe C., Hotoda N., Sasagawa N., Sehara-Fujisawa A., Maruyama K., and, Ishiura S., (2007) ADAM19 is tightly associated with constitutive Alzheimer's disease APP alpha-secretase in A172 cells. Biochem. Biophys. Res. Commun. 352, 111-117. (Pubitemid 44821101)
133. van Tetering G., van Diest P., Verlaan I., van der Wall E., Kopan R., and, Vooijs M., (2009) Metalloprotease ADAM10 is required for Notch1 site 2 cleavage. J. Biol. Chem. 284, 31018-31027.
134. Tousseyn T., Thathiah A., Jorissen E., et al. (2009) ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase. J. Biol. Chem. 284, 11738-11747.
135. Uemura K., Kihara T., Kuzuya A., Okawa K., Nishimoto T., Ninomiya H., Sugimoto H., Kinoshita A., and, Shimohama S., (2006) Characterization of sequential N-cadherin cleavage by ADAM10 and PS1. Neurosci. Lett. 402, 278-283. (Pubitemid 43850164)
136. Vaisar T., Kassim S. Y., Gomez I. G., Green P. S., Hargarten S., Gough P. J., Parks W. C., Wilson C. L., Raines E. W., and, Heinecke J. W., (2009) MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Mol. Cell Proteomics 8, 1044-1060.
137. Vincent B., and, Checler F., (2011) alpha-Secretase in Alzheimer's disease and beyond: mechanistic, regulation and function in the shedding of membrane proteins. Curr. Alzheimer Res. [Epub ahead of print].
138. Vingtdeux V., Hamdane M., Loyens A., et al. (2007) Alkalizing drugs induce accumulation of amyloid precursor protein by-products in luminal vesicles of multivesicular bodies. J. Biol. Chem. 282, 18197-18205. (Pubitemid 47100204)
139. Vohra B. P., Sasaki Y., Miller B. R., Chang J., DiAntonio A., and, Milbrandt J., (2010) Amyloid precursor protein cleavage-dependent and -independent axonal degeneration programs share a common nicotinamide mononucleotide adenylyltransferase 1-sensitive pathway. J. Neurosci. 304, 13729-13738.
140. Walsh D. M., and, Selkoe D. J., (2007) A beta oligomers-a decade of discovery. J. Neurochem. 101, 1172-1184.
141. Wang R., Meschia J. F., Cotter R. J., and, Sisodia S. S., (1991) Secretion of the beta/A4 amyloid precursor protein. Identification of a cleavage site in cultured mammalian cells. J. Biol. Chem. 266, 16960-16964.
142. Weskamp G., Cai H., Brodie T. A., Higashyama S., Manova K., Ludwig T., and, Blobel C. P., (2002) Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22, 1537-1544. (Pubitemid 34150789)